CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease

AIMS: It has been reported that cytochrome P450 (CYP)3A activity increases significantly in patients with end stage renal disease (ESRD) after kidney transplantation, with wide interindividual variability in the degree of increase. The aim of this study was to evaluate the influence of CYP3A5 polymo...

詳細記述

保存先:
書誌詳細
出版年:Br J Clin Pharmacol
主要な著者: Suzuki, Yosuke, Fujioka, Takashi, Sato, Fuminori, Matsumoto, Kunihiro, Muraya, Nanako, Tanaka, Ryota, Sato, Yuhki, Ohno, Keiko, Mimata, Hiromitsu, Kishino, Satoshi, Itoh, Hiroki
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2015
主題:
Pharmacogenetics
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4693498/
https://ncbi.nlm.nih.gov/pubmed/26773964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12733
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料